Oncimmune Holdings PLC Grant of options (6778O)
09 November 2016 - 5:25AM
UK Regulatory
TIDMONC
RNS Number : 6778O
Oncimmune Holdings PLC
08 November 2016
8 November 2016
Oncimmune Holdings plc
("Oncimmune" or the "Company")
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PDMR AND
PERSONS CLOSELY ASSOCIATED WITH THEM
Oncimmune Holdings plc (AIM: ONC.L), a leading early cancer
detection company developing and commercialising its proprietary
EarlyCDT(R) platform technology, today announces that on 8 November
2016, options over ordinary shares of the Company were awarded to
certain Directors and certain PDMRs under the Company's 2016 Share
Option Plan (an amalgamation of the Company's 2005 and 2007 Share
Option Plans) as follows.
Name Position Number Option Percentage
of share exercise of issued
options price share capital
awarded per share (%)
(pence)
--------------------------- ------------------- ---------- ----------- ---------------
Non-executive
Meinhard Schmidt Chairman 120,370 108 0.236
--------------------------- ------------------- ---------- ----------- ---------------
Chief Executive
Geoffrey Hamilton-Fairley Officer 528,273 1 1.035
--------------------------- ------------------- ---------- ----------- ---------------
119,875 108 0.235
----------------------------------------------- ---------- ----------- ---------------
Chief Financial
Andrew Millet Officer 92,593 108 0.181
--------------------------- ------------------- ---------- ----------- ---------------
Chief Operational
Andrea Murray Scientist 41,667 108 0.082
--------------------------- ------------------- ---------- ----------- ---------------
Chief Commercial
Maarten Brusse Officer 74,074 108 0.145
--------------------------- ------------------- ---------- ----------- ---------------
The options are subject to the rules of the 2016 Share Option
Plan and vest in five equal annual parts, the first fifth vesting
on 7 November 2017 and each year thereafter for a further four
years, subject to continued employment. Unless otherwise indicated
in the table above, the options are exercisable at 108 pence, being
the mid-market closing price of the Company's ordinary shares on 7
November 2016
For further information:
Oncimmune Holdings plc
Geoffrey Hamilton-Fairley, Chief Executive Officer
contact@oncimmune.co.uk
Zeus Capital Limited (Nominated Adviser and Broker)
Phil Walker, Giles Balleny, Dominic Wilson
+44 (0) 203 829 5000
Media enquiries:
Consilium Strategic Communications
Chris Gardner, Mary-Jane Elliott, Matthew Neal, Lindsey
Neville
oncimmune@consilium-comms.com
+44 (0) 20 3709 5708
1 Details of the person discharging managerial responsibilities/person closely associated
---- ----------------------------------------------------------------------------------------------------------------
a) Name Meinhard Schmidt
---- ------------------------------------------------------- -------------------------------------------------------
2 Reason for the notification
---- ----------------------------------------------------------------------------------------------------------------
Non-Executive Chairman, Director
a) Position/status
---- ------------------------------------------------------- -------------------------------------------------------
b) Initial notification/Amendment Initial Notification
---- ------------------------------------------------------- -------------------------------------------------------
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer
or auction monitor
---- ----------------------------------------------------------------------------------------------------------------
a) Name Oncimmune Holdings plc
---- ------------------------------------------------------- -------------------------------------------------------
b) LEI N/A
---- ------------------------------------------------------- -------------------------------------------------------
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date; and (iv) each place where transactions have been
conducted
---- ----------------------------------------------------------------------------------------------------------------
a) Description of the financial instrument, type of options over 1p ordinary shares - 2016 Share Option
instrument Plan
Identification code
ISIN GB00BYQ94H38
---- ------------------------------------------------------- -------------------------------------------------------
b) Nature of the transaction Grant of options over ordinary shares
---- ------------------------------------------------------- -------------------------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
---------- ----------
N/A 120,370
---------- ----------
---- ------------------------------------------------------- -------------------------------------------------------
d) Aggregated information Price(s) Volume(s)
---------- ----------
N/A 120,370
---------- ----------
---- ------------------------------------------------------- -------------------------------------------------------
e) Date of the transaction 8 November 2016
---- ------------------------------------------------------- -------------------------------------------------------
f) Place of the transaction N/A
---- ------------------------------------------------------- -------------------------------------------------------
1 Details of the person discharging managerial responsibilities/person closely associated
---- ----------------------------------------------------------------------------------------------------------------
a) Name Geoffrey Hamilton-Fairley
---- ------------------------------------------------------- -------------------------------------------------------
2 Reason for the notification
---- ----------------------------------------------------------------------------------------------------------------
Chief Executive Officer
a) Position/status
---- ------------------------------------------------------- -------------------------------------------------------
b) Initial notification/Amendment Initial Notification
---- ------------------------------------------------------- -------------------------------------------------------
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer
or auction monitor
---- ----------------------------------------------------------------------------------------------------------------
a) Name Oncimmune Holdings Plc
---- ------------------------------------------------------- -------------------------------------------------------
b) LEI N/A
---- ------------------------------------------------------- -------------------------------------------------------
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date; and (iv) each place where transactions have been
conducted
---- ----------------------------------------------------------------------------------------------------------------
a) Description of the financial instrument, type of options over 1p ordinary shares - 2016 Share Option
instrument Plan
Identification code ISIN GB00BYQ94H38
---- ------------------------------------------------------- -------------------------------------------------------
b) Nature of the transaction Grant of options over ordinary shares
---- ------------------------------------------------------- -------------------------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
---------- ----------
N/A 528,273
---------- ----------
N/A 119.875
---------- ----------
---- ------------------------------------------------------- -------------------------------------------------------
d) Aggregated information Price(s) Volume(s)
---------- ----------
N/A 648,148
---------- ----------
---- ------------------------------------------------------- -------------------------------------------------------
e) Date of the transaction 8 November 2016
---- ------------------------------------------------------- -------------------------------------------------------
f) Place of the transaction N/A
---- ------------------------------------------------------- -------------------------------------------------------
1 Details of the person discharging managerial responsibilities/person closely associated
---- ----------------------------------------------------------------------------------------------------------------
a) Name Andrew Millet
---- ------------------------------------------------------- -------------------------------------------------------
2 Reason for the notification
---- ----------------------------------------------------------------------------------------------------------------
Chief Financial Officer
a) Position/status
---- ------------------------------------------------------- -------------------------------------------------------
b) Initial notification/Amendment Initial Notification
---- ------------------------------------------------------- -------------------------------------------------------
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer
or auction monitor
---- ----------------------------------------------------------------------------------------------------------------
a) Name Oncimmune Holdings Plc
---- ------------------------------------------------------- -------------------------------------------------------
b) LEI N/A
---- ------------------------------------------------------- -------------------------------------------------------
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date; and (iv) each place where transactions have been
conducted
---- ----------------------------------------------------------------------------------------------------------------
a) Description of the financial instrument, type of options over 1p ordinary shares - 2016 Share Option
instrument Plan
Identification code ISIN GB00BYQ94H38
---- ------------------------------------------------------- -------------------------------------------------------
b) Nature of the transaction Grant of options over ordinary shares
---- ------------------------------------------------------- -------------------------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
---------- ----------
N/A 92,593
---------- ----------
---- ------------------------------------------------------- -------------------------------------------------------
d) Aggregated information Price(s) Volume(s)
---------- ----------
N/A 92,593
---------- ----------
---- ------------------------------------------------------- -------------------------------------------------------
e) Date of the transaction 8 November 2016
---- ------------------------------------------------------- -------------------------------------------------------
f) Place of the transaction N/A
---- ------------------------------------------------------- -------------------------------------------------------
1 Details of the person discharging managerial responsibilities/person closely associated
---- ----------------------------------------------------------------------------------------------------------------
a) Name Andrea Murray
---- ------------------------------------------------------- -------------------------------------------------------
2 Reason for the notification
---- ----------------------------------------------------------------------------------------------------------------
Chief Operational Scientist and PDMR
a) Position/status
---- ------------------------------------------------------- -------------------------------------------------------
b) Initial notification/Amendment Initial Notification
---- ------------------------------------------------------- -------------------------------------------------------
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer
or auction monitor
---- ----------------------------------------------------------------------------------------------------------------
a) Name Oncimmune Holdings Plc
---- ------------------------------------------------------- -------------------------------------------------------
b) LEI N/A
---- ------------------------------------------------------- -------------------------------------------------------
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date; and (iv) each place where transactions have been
conducted
---- ----------------------------------------------------------------------------------------------------------------
a) Description of the financial instrument, type of options over 1p ordinary shares - 2016 Share Option
instrument Plan
Identification code ISIN GB00BYQ94H38
---- ------------------------------------------------------- -------------------------------------------------------
b) Nature of the transaction Grant of options over ordinary shares
---- ------------------------------------------------------- -------------------------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
---------- ----------
N/A 41,667
---------- ----------
---- ------------------------------------------------------- -------------------------------------------------------
d) Aggregated information Price(s) Volume(s)
---------- ----------
N/A 41,667
---------- ----------
---- ------------------------------------------------------- -------------------------------------------------------
e) Date of the transaction 8 November 2016
---- ------------------------------------------------------- -------------------------------------------------------
f) Place of the transaction N/A
---- ------------------------------------------------------- -------------------------------------------------------
1 Details of the person discharging managerial responsibilities/person closely associated
---- ----------------------------------------------------------------------------------------------------------------
a) Name Maarten Brusse
---- ------------------------------------------------------- -------------------------------------------------------
2 Reason for the notification
---- ----------------------------------------------------------------------------------------------------------------
Chief Commercial Officer and PDMR
a) Position/status
---- ------------------------------------------------------- -------------------------------------------------------
b) Initial notification/Amendment Initial Notification
---- ------------------------------------------------------- -------------------------------------------------------
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer
or auction monitor
---- ----------------------------------------------------------------------------------------------------------------
a) Name Oncimmune Holdings Plc
---- ------------------------------------------------------- -------------------------------------------------------
b) LEI N/A
---- ------------------------------------------------------- -------------------------------------------------------
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date; and (iv) each place where transactions have been
conducted
---- ----------------------------------------------------------------------------------------------------------------
a) Description of the financial instrument, type of options over 1p ordinary shares - 2016 Share Option
instrument Plan
Identification code ISIN GB00BYQ94H38
---- ------------------------------------------------------- -------------------------------------------------------
b) Nature of the transaction Grant of options over ordinary shares
---- ------------------------------------------------------- -------------------------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
---------- ----------
N/A 74,074
---------- ----------
---- ------------------------------------------------------- -------------------------------------------------------
d) Aggregated information Price(s) Volume(s)
---------- ----------
N/A 74,074
---------- ----------
---- ------------------------------------------------------- -------------------------------------------------------
e) Date of the transaction 8 November 2016
---- ------------------------------------------------------- -------------------------------------------------------
f) Place of the transaction N/A
---- ------------------------------------------------------- -------------------------------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHBIBDBSDGBGLI
(END) Dow Jones Newswires
November 08, 2016 13:25 ET (18:25 GMT)
Oncimmune (LSE:ONC)
Historical Stock Chart
From Apr 2024 to May 2024
Oncimmune (LSE:ONC)
Historical Stock Chart
From May 2023 to May 2024